Cargando…

High-biologically effective dose palliative radiotherapy for a tumor thrombus might improve the long-term prognosis of hepatocellular carcinoma: a retrospective study

BACKGROUND: This study aimed to highlight the type of tumor thrombus and identify the prognostic factors influencing the long-term survival outcomes in patients with hepatocellular carcinoma (HCC) having a tumor thrombus. A tumor thrombus in HCC is associated with poor prognosis. METHODS: Eighty pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Xiang-quan, Dong, Ya-ping, Wu, Jun-xin, He, Jun-yan, Le, Yu-yin, Du, Kai-xin, Peng, Qing-qin, Li, Jin-luan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452386/
https://www.ncbi.nlm.nih.gov/pubmed/28569169
http://dx.doi.org/10.1186/s13014-017-0831-y
_version_ 1783240408032083968
author Kong, Xiang-quan
Dong, Ya-ping
Wu, Jun-xin
He, Jun-yan
Le, Yu-yin
Du, Kai-xin
Peng, Qing-qin
Li, Jin-luan
author_facet Kong, Xiang-quan
Dong, Ya-ping
Wu, Jun-xin
He, Jun-yan
Le, Yu-yin
Du, Kai-xin
Peng, Qing-qin
Li, Jin-luan
author_sort Kong, Xiang-quan
collection PubMed
description BACKGROUND: This study aimed to highlight the type of tumor thrombus and identify the prognostic factors influencing the long-term survival outcomes in patients with hepatocellular carcinoma (HCC) having a tumor thrombus. A tumor thrombus in HCC is associated with poor prognosis. METHODS: Eighty patients diagnosed with HCC having a tumor thrombus between May 2006 and April 2014 were enrolled in this study. Age, gender, clinical characteristics, laboratory findings, Child-Pugh classification, performance status (ECOG), types of tumor thrombi, radiotherapy method, biologically effective dose (BED), and primary treatment method were analyzed to identify the prognostic factors associated with the overall survival (OS) rates. Statistical analyses were performed using SPSS version 19.0. RESULTS: The median follow-up duration was 24 months (range 6–90). The 1-, 3-, and 5-year OS rates of the patients were 77.6%, 37.6%, and 18.8%, respectively. On univariate analysis, gender, radiotherapy method, BED, types of tumor thrombi, Child-Pugh classification, ECOG, and total bilirubin were associated with OS (P < 0.001, P = 0.001, P = 0.016, P = 0.003, P < 0.001, P < 0.001, P = 0.039, respectively). The prognostic factors for OS in multi-variate analyses were gender (P < 0.001), BED (P = 0.044), Child Pugh classification (P = 0.020), performance status (ECOG) (P = 0.004), and types of tumor thrombi (P = 0.001). The median OS for the high-BED group was better than that for the low-BED groups (42 months vs. 19 months, P = 0.016). CONCLUSIONS: Gender, BED, performance status (ECOG), Child-Pugh classification, and types of tumor thrombi seemed to affect OS, and a stepwise decrease in survival was observed with the types of tumor thrombi ranging from I to IV. High-BED palliative radiotherapy might improve the long-term outcomes for patients with HCC having a tumor thrombus.
format Online
Article
Text
id pubmed-5452386
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54523862017-06-01 High-biologically effective dose palliative radiotherapy for a tumor thrombus might improve the long-term prognosis of hepatocellular carcinoma: a retrospective study Kong, Xiang-quan Dong, Ya-ping Wu, Jun-xin He, Jun-yan Le, Yu-yin Du, Kai-xin Peng, Qing-qin Li, Jin-luan Radiat Oncol Research BACKGROUND: This study aimed to highlight the type of tumor thrombus and identify the prognostic factors influencing the long-term survival outcomes in patients with hepatocellular carcinoma (HCC) having a tumor thrombus. A tumor thrombus in HCC is associated with poor prognosis. METHODS: Eighty patients diagnosed with HCC having a tumor thrombus between May 2006 and April 2014 were enrolled in this study. Age, gender, clinical characteristics, laboratory findings, Child-Pugh classification, performance status (ECOG), types of tumor thrombi, radiotherapy method, biologically effective dose (BED), and primary treatment method were analyzed to identify the prognostic factors associated with the overall survival (OS) rates. Statistical analyses were performed using SPSS version 19.0. RESULTS: The median follow-up duration was 24 months (range 6–90). The 1-, 3-, and 5-year OS rates of the patients were 77.6%, 37.6%, and 18.8%, respectively. On univariate analysis, gender, radiotherapy method, BED, types of tumor thrombi, Child-Pugh classification, ECOG, and total bilirubin were associated with OS (P < 0.001, P = 0.001, P = 0.016, P = 0.003, P < 0.001, P < 0.001, P = 0.039, respectively). The prognostic factors for OS in multi-variate analyses were gender (P < 0.001), BED (P = 0.044), Child Pugh classification (P = 0.020), performance status (ECOG) (P = 0.004), and types of tumor thrombi (P = 0.001). The median OS for the high-BED group was better than that for the low-BED groups (42 months vs. 19 months, P = 0.016). CONCLUSIONS: Gender, BED, performance status (ECOG), Child-Pugh classification, and types of tumor thrombi seemed to affect OS, and a stepwise decrease in survival was observed with the types of tumor thrombi ranging from I to IV. High-BED palliative radiotherapy might improve the long-term outcomes for patients with HCC having a tumor thrombus. BioMed Central 2017-05-31 /pmc/articles/PMC5452386/ /pubmed/28569169 http://dx.doi.org/10.1186/s13014-017-0831-y Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Kong, Xiang-quan
Dong, Ya-ping
Wu, Jun-xin
He, Jun-yan
Le, Yu-yin
Du, Kai-xin
Peng, Qing-qin
Li, Jin-luan
High-biologically effective dose palliative radiotherapy for a tumor thrombus might improve the long-term prognosis of hepatocellular carcinoma: a retrospective study
title High-biologically effective dose palliative radiotherapy for a tumor thrombus might improve the long-term prognosis of hepatocellular carcinoma: a retrospective study
title_full High-biologically effective dose palliative radiotherapy for a tumor thrombus might improve the long-term prognosis of hepatocellular carcinoma: a retrospective study
title_fullStr High-biologically effective dose palliative radiotherapy for a tumor thrombus might improve the long-term prognosis of hepatocellular carcinoma: a retrospective study
title_full_unstemmed High-biologically effective dose palliative radiotherapy for a tumor thrombus might improve the long-term prognosis of hepatocellular carcinoma: a retrospective study
title_short High-biologically effective dose palliative radiotherapy for a tumor thrombus might improve the long-term prognosis of hepatocellular carcinoma: a retrospective study
title_sort high-biologically effective dose palliative radiotherapy for a tumor thrombus might improve the long-term prognosis of hepatocellular carcinoma: a retrospective study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452386/
https://www.ncbi.nlm.nih.gov/pubmed/28569169
http://dx.doi.org/10.1186/s13014-017-0831-y
work_keys_str_mv AT kongxiangquan highbiologicallyeffectivedosepalliativeradiotherapyforatumorthrombusmightimprovethelongtermprognosisofhepatocellularcarcinomaaretrospectivestudy
AT dongyaping highbiologicallyeffectivedosepalliativeradiotherapyforatumorthrombusmightimprovethelongtermprognosisofhepatocellularcarcinomaaretrospectivestudy
AT wujunxin highbiologicallyeffectivedosepalliativeradiotherapyforatumorthrombusmightimprovethelongtermprognosisofhepatocellularcarcinomaaretrospectivestudy
AT hejunyan highbiologicallyeffectivedosepalliativeradiotherapyforatumorthrombusmightimprovethelongtermprognosisofhepatocellularcarcinomaaretrospectivestudy
AT leyuyin highbiologicallyeffectivedosepalliativeradiotherapyforatumorthrombusmightimprovethelongtermprognosisofhepatocellularcarcinomaaretrospectivestudy
AT dukaixin highbiologicallyeffectivedosepalliativeradiotherapyforatumorthrombusmightimprovethelongtermprognosisofhepatocellularcarcinomaaretrospectivestudy
AT pengqingqin highbiologicallyeffectivedosepalliativeradiotherapyforatumorthrombusmightimprovethelongtermprognosisofhepatocellularcarcinomaaretrospectivestudy
AT lijinluan highbiologicallyeffectivedosepalliativeradiotherapyforatumorthrombusmightimprovethelongtermprognosisofhepatocellularcarcinomaaretrospectivestudy